Low-grade serous ovarian carcinoma: an evolution toward targeted therapy.
Voutsadakis IA.
Int J Gynecol Cancer. 2020 Oct;30(10):1619-1626. doi: 10.1136/ijgc-2019-000832. Epub 2019 Nov 27.
Low-grade serous ovarian cancer: expert consensus report on the state of the science.
Grisham RN, Slomovitz BM, Andrews N, Banerjee S, Brown J, Carey MS, Chui H, Coleman RL, Fader AN, Gaillard S, Gourley C, Sood AK, Monk BJ, Moore KN, Ray-Coquard I, Shih IM, Westin SN, Wong KK, Gershenson DM.
Int J Gynecol Cancer. 2023 Sep 4;33(9):1331-1344. doi: 10.1136/ijgc-2023-004610.
Low-grade serous ovarian carcinoma: A comprehensive literature review.
Goulding EA, Simcock B, McLachlan J, van der Griend R, Sykes P.
Aust N Z J Obstet Gynaecol. 2020 Feb;60(1):27-33. doi: 10.1111/ajo.13105. Epub 2019 Dec 17.
Targeting BRAF pathway in low-grade serous ovarian cancer.
Perrone C, Angioli R, Luvero D, Giannini A, Di Donato V, Cuccu I, Muzii L, Raspagliesi F, Bogani G.
J Gynecol Oncol. 2024 Jul;35(4):e104. doi: 10.3802/jgo.2024.35.e104. Epub 2024 May 14.
CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma.
Walton J, Blagih J, Ennis D, Leung E, Dowson S, Farquharson M, Tookman LA, Orange C, Athineos D, Mason S, Stevenson D, Blyth K, Strathdee D, Balkwill FR, Vousden K, Lockley M, McNeish IA.
Cancer Res. 2016 Oct 15;76(20):6118-6129. doi: 10.1158/0008-5472.CAN-16-1272. Epub 2016 Aug 16.
Low-grade serous ovarian cancer: State of the science.
Slomovitz B, Gourley C, Carey MS, Malpica A, Shih IM, Huntsman D, Fader AN, Grisham RN, Schlumbrecht M, Sun CC, Ludemann J, Cooney GA, Coleman R, Sood AK, Mahdi H, Wong KK, Covens A, O'Malley DM, Lecuru F, Cobb LP, Caputo TA, May T, Huang M, Siemon J, Fernández ML, Ray-Coquard I, Gershenson DM.
Gynecol Oncol. 2020 Mar;156(3):715-725. doi: 10.1016/j.ygyno.2019.12.033. Epub 2020 Jan 20.
Low grade serous ovarian cancer: Unpicking drivers of outcome.
Gourley C, Hollis RL.
Gynecol Oncol. 2022 Nov;167(2):137-138. doi: 10.1016/j.ygyno.2022.10.007.
Novel therapeutics in low-grade serous ovarian cancer.
Cobb L, Gershenson D.
Int J Gynecol Cancer. 2023 Mar 6;33(3):377-384. doi: 10.1136/ijgc-2022-003677.
Targeted Therapies in Low-Grade Serous Ovarian Cancers.
Gonzalez A, Nagel CI, Haight PJ.
Curr Treat Options Oncol. 2024 Jul;25(7):854-868. doi: 10.1007/s11864-024-01205-4. Epub 2024 Jun 13.
Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategy.
Della Pepa C, Tonini G, Santini D, Losito S, Pisano C, Di Napoli M, Cecere SC, Gargiulo P, Pignata S.
Cancer Treat Rev. 2015 Feb;41(2):136-43. doi: 10.1016/j.ctrv.2014.12.003. Epub 2014 Dec 23.
